Drug intelligence / Profile preview

suyin jiedu

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Suyin Jiedu is a traditional Chinese medicine (TCM) prescription used in clinical practice, particularly for the treatment of chronic kidney disease (CKD) stages 3-5 characterized by kidney deficiency and turbid toxin type. It has also been studied for its effects on blood-heat psoriasis. The formula is composed of multiple herbal ingredients, typical of TCM compound prescriptions, and is believed to act through multi-target and multi-pathway mechanisms common to TCM approaches. Its reported benefits include improving renal function parameters in CKD patients and modulating immune or inflammatory responses associated with these conditions[5][7]. The precise mechanism of action remains unclear due to the complexity of its herbal composition.

Other names: Suyin Jiedu Prescription

Beyond the preview

Go deeper on suyin jiedu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on suyin jiedu.

Explore the full profile